Werbung
Werbung

LMAT

LMAT logo

LeMaitre Vascular, Inc.

84.99
USD
Gesponsert
-0.05
-0.06%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

85.00

+0.01
+0.01%

LMAT Ergebnisberichte

Positives Überraschungsverhältnis

LMAT übertreffen die 26 der letzten 40Schätzungen.

65%

Nächster Bericht

Datum des nächsten Berichts
25. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$64.25M
/
$0.67
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+5.24%
/
+8.06%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+15.31%
/
+36.73%

LeMaitre Vascular, Inc. earnings per share and revenue

On 06. Nov. 2025, LMAT reported earnings of 0.62 USD per share (EPS) for Q3 25, beating the estimate of 0.57 USD, resulting in a 7.38% surprise. Revenue reached 61.05 million, compared to an expected 63.42 million, with a -3.74% difference. The market reacted with a +1.43% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 13 analysts forecast an EPS of 0.67 USD, with revenue projected to reach 64.25 million USD, implying an increase of 8.06% EPS, and increase of 5.24% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Tilray Brands, Inc. Common Stock
Report Date
08. Jan. 2026 For Q2 26
Estimate
-$0.20
Aktuell
-$0.41
Überraschung
-100.98%
logo
Neogen Corp
Report Date
08. Jan. 2026 For Q2 26
Estimate
$0.05
Aktuell
$0.10
Überraschung
+78.25%
FAQ
For Q3 2025, LeMaitre Vascular, Inc. reported EPS of $0.62, beating estimates by 7.38%, and revenue of $61.05M, -3.74% below expectations.
The stock price moved up 1.43%, changed from $85.60 before the earnings release to $86.82 the day after.
The next earning report is scheduled for 25. Feb. 2026.
Based on 13 analysts, LeMaitre Vascular, Inc. is expected to report EPS of $0.67 and revenue of $64.25M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung